2011
Thioredoxin reductase, an emerging target for anticancer metallodrugs. Enzyme inhibition by cytotoxic gold(III) compounds studied with combined mass spectrometry and biochemical assays.
Gabbiani, C. and Mastrobuoni, G. and Sorrentino, F. and Dani, B. and Rigobello, M.P. and Bindoli, A. and Cinellu, M.A. and Pieraccini, G. and Messori, L. and Casini, A.
MedChemComm 2
(1): 50-54.
January 2011
This list was generated on Thu Mar 28 02:36:56 2024 CET.